-transparent.png){kind=logo}
Site-directed mutagenesis of human adenylate kinase (AK) was carried out on residues His36, Lys55, and the C-terminal segment (Val182, V186, and Leu193). Five mutants [(H36T, K55G, V182G, V186S, and L193Stop (deletion of residues 193-194)] were generated and analyzed by steady-state kinetics. H36T, K55G, and L193Stop mutants showed an increase of K(m) values (19.8-, 19.7-, and 11.3-fold) for AMP2- compared to that for the wild-type enzyme, and these residues appeared to interact with AMP2-. V182G showed an increased K(m) value (7.4-fold) for MgATP2-. Therefore, V182 may be essential for interaction with MgATP2-. V186S increased the K(m) value (7.0- and 7.5-fold) for MgATP2- and AMP2-. V186 may thus interact with both substrates. The C-terminal domain of AK appears to be essential for MgATP2- and AMP2- binding.
T Ayabe, and
S K Park, and
H Nagahama, and
H Maruyama, and
M Sumida, and
H Takenaka, and
O Takenaka, and
T Onitsuka, and
M Hamada
January 1996,
Enzyme & protein,
T Ayabe, and
S K Park, and
H Nagahama, and
H Maruyama, and
M Sumida, and
H Takenaka, and
O Takenaka, and
T Onitsuka, and
M Hamada
January 1995,
Methods in enzymology,
T Ayabe, and
S K Park, and
H Nagahama, and
H Maruyama, and
M Sumida, and
H Takenaka, and
O Takenaka, and
T Onitsuka, and
M Hamada
October 2002,
Biochemistry,
T Ayabe, and
S K Park, and
H Nagahama, and
H Maruyama, and
M Sumida, and
H Takenaka, and
O Takenaka, and
T Onitsuka, and
M Hamada
November 1993,
Journal of biochemistry,
T Ayabe, and
S K Park, and
H Nagahama, and
H Maruyama, and
M Sumida, and
H Takenaka, and
O Takenaka, and
T Onitsuka, and
M Hamada
June 2004,
Biochemistry,
T Ayabe, and
S K Park, and
H Nagahama, and
H Maruyama, and
M Sumida, and
H Takenaka, and
O Takenaka, and
T Onitsuka, and
M Hamada
July 1991,
Biochemistry,
T Ayabe, and
S K Park, and
H Nagahama, and
H Maruyama, and
M Sumida, and
H Takenaka, and
O Takenaka, and
T Onitsuka, and
M Hamada
February 1996,
Biochemistry and molecular biology international,
T Ayabe, and
S K Park, and
H Nagahama, and
H Maruyama, and
M Sumida, and
H Takenaka, and
O Takenaka, and
T Onitsuka, and
M Hamada
January 1985,
Ciba Foundation symposium,
T Ayabe, and
S K Park, and
H Nagahama, and
H Maruyama, and
M Sumida, and
H Takenaka, and
O Takenaka, and
T Onitsuka, and
M Hamada
June 1995,
BioTechniques,
T Ayabe, and
S K Park, and
H Nagahama, and
H Maruyama, and
M Sumida, and
H Takenaka, and
O Takenaka, and
T Onitsuka, and
M Hamada
November 1993,
FEBS letters,
